These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10525118)

  • 1. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo.
    Praticò D
    Atherosclerosis; 1999 Nov; 147(1):1-10. PubMed ID: 10525118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
    Praticò D; Rokach J; Lawson J; FitzGerald GA
    Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.
    Song WL; Paschos G; Fries S; Reilly MP; Yu Y; Rokach J; Chang CT; Patel P; Lawson JA; Fitzgerald GA
    J Biol Chem; 2009 Aug; 284(35):23636-43. PubMed ID: 19520854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F(2) isoprostanes, potential specific markers of oxidative damage in human retina.
    Nourooz-Zadeh J; Pereira P
    Ophthalmic Res; 2000; 32(4):133-7. PubMed ID: 10828732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes and other markers of peroxidation in atherosclerosis.
    Patrignani P; Tacconelli S
    Biomarkers; 2005 Nov; 10 Suppl 1():S24-9. PubMed ID: 16298908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients.
    Basu S
    Toxicology; 2003 Jul; 189(1-2):113-27. PubMed ID: 12821287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B; Nofer TW; Wasowicz W
    Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metabolites from type III F2-isoprostane diastereoisomers by mass spectrometry.
    Chiabrando C; Rivalta C; Bagnati R; Valagussa A; Durand T; Guy A; Villa P; Rossi JC; Fanelli R
    J Lipid Res; 2002 Mar; 43(3):495-509. PubMed ID: 11893786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
    Praticò D; Iuliano L; Mauriello A; Spagnoli L; Lawson JA; Rokach J; Maclouf J; Violi F; FitzGerald GA
    J Clin Invest; 1997 Oct; 100(8):2028-34. PubMed ID: 9329967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
    Mezzetti A; Cipollone F; Cuccurullo F
    Cardiovasc Res; 2000 Aug; 47(3):475-88. PubMed ID: 10963721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
    Roberts LJ; Morrow JD
    Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation.
    Tacconelli S; Capone ML; Patrignani P
    Methods Mol Biol; 2010; 644():165-78. PubMed ID: 20645173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
    Patrono C; FitzGerald GA
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2309-15. PubMed ID: 9409197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into oxidative stress: the isoprostanes.
    Montuschi P; Barnes P; Roberts LJ
    Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.
    Roberts LJ; Morrow JD
    Ann N Y Acad Sci; 1994 Nov; 744():237-42. PubMed ID: 7825845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
    Morrow JD
    Curr Pharm Des; 2006; 12(8):895-902. PubMed ID: 16533158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.